Form 8-K - Current report:
SEC Accession No. 0001564590-21-044367
Filing Date
2021-08-16
Accepted
2021-08-13 17:36:37
Documents
12
Period of Report
2021-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-8k_20210813.htm   iXBRL 8-K 30782
  Complete submission text file 0001564590-21-044367.txt   159953

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210813.xsd EX-101.SCH 5792
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210813_lab.xml EX-101.LAB 19469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210813_pre.xml EX-101.PRE 11642
5 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20210813_htm.xml XML 3567
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 211173536
SIC: 2834 Pharmaceutical Preparations